US Patent 7897354 Kinase peptides and antibodies
Patent 7897354 was granted and assigned to Nuclea Biotechnologies on March, 2011 by the United States Patent and Trademark Office.
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+336 characters)
Article
Patent abstract
The invention relates to novel kinase peptides and antibodies, as well as nucleic acids related to them. The peptides, antibodies and the nucleic acids are useful for the detection, staging and monitoring of the progression of a kinase-mediated disease, as well as for determining or monitoring the efficacy of treatment.
Edits on 13 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07897354 Kinase peptides and antibodies US Patent 7897354 Kinase peptides and antibodies
Infobox
Patent Number
0789735400
Patent Number
789735400
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078973540
Date of Patent
March 1, 2011
0Patent Application Number
120808680
Date Filed
April 7, 2008
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078973540
Date of Patent
March 1, 2011
0Patent Application Number
120808680
Date Filed
April 7, 2008
0Official Website
Patent Primary Examiner
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07897354 Kinase peptides and antibodies
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07897354
Date of patent
March 1, 2011
Patent application number
12080868
Date Filed
April 7, 2008
Patent primary examiner
Find more entities like US Patent 7897354 Kinase peptides and antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
